Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable.

Barzegar Behrooz, Amir; Talaie, Zahra; Syahir, Amir

Barzegar Behrooz, Amir; Talaie, Zahra; Syahir, Amir.

Afiliação

Barzegar Behrooz A; Nanobiotechnology Research Group, Department of Biochemistry, Faculty of Biotechnology and Biomolecular Science, Universiti Putra Malaysia, Serdang 43400, Malaysia.
Talaie Z; School of Biology, Nour Danesh Institute of Higher Education, Isfahan 84156-83111, Iran.
Syahir A; Nanobiotechnology Research Group, Department of Biochemistry, Faculty of Biotechnology and Biomolecular Science, Universiti Putra Malaysia, Serdang 43400, Malaysia.

Pharmaceutics ; 14(8)2022 Aug 15.

Article em En | MEDLINE | ID: mdl-36015322

Palavras-chave

drug delivery; glioblastoma; nanocarriers; nanomedicine; nanotechnology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malásia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google